PANACEABIO

Panacea Biotec Share PricePanacea Biotec

₹113.5
1.75 (1.57%)
As on 23 March, 2023 | 01:14 BSE: 531349 NSE: PANACEABIO

Panacea Biotec Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Panacea Biotec

Start SIP

Panacea Biotec Share Price

  • Over 1 Month -6%
  • Over 3 Month -20.93%
  • Over 6 Month -19.82%
  • Over 1 Year -38%

Panacea Biotec Key Statistics

P/E Ratio 0.6
PEG Ratio 0
Market Cap Cr 695
Price to Book Ratio 0.8
EPS -15.3
Dividend 0
Relative Strength Index 34.38
Money Flow Index 40.61
MACD Signal -3.01
Average True Range 4.09

Panacea Biotec Investment Rating

  • Master Rating:
  • Panacea Biotec (Nse) has an operating revenue of Rs. 471.75 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 219% is great, ROE of 126% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 70 which is a FAIR score but needs to improve its earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Panacea Biotec Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 72496142
Operating Expenses Qtr Cr 605513361
Operating Profit Qtr Cr 12-6-72-19
Depreciation Qtr Cr 6667
Interest Qtr Cr 3221
Tax Qtr Cr 0000
Net Profit Qtr Cr 13-7-74-25

Panacea Biotec Technicals

EMA & SMA

Current Price
₹113.5
1.75 (1.57%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 117.97
  • 50 Day
  • 123.86
  • 100 Day
  • 129.72
  • 200 Day
  • 141.52
  • 20 Day
  • 118.55
  • 50 Day
  • 124.65
  • 100 Day
  • 132.69
  • 200 Day
  • 134.26

Panacea Biotec Resistance and Support

PIVOT
₹111.72
Resistance
First Resistance 113.54
Second Resistance 115.32
Third Resistance 117.14
RSI 34.39
MFI 40.61
MACD Single Line -3.01
MACD -3.55
Support
First Resistance 109.94
Second Resistance 108.12
Third Resistance 106.34

Panacea Biotec Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 40,646 2,478,187 60.97
Week 51,425 3,170,878 61.66
1 Month 59,258 3,864,835 65.22
6 Month 125,072 5,454,377 43.61

Panacea Biotec Result Highlights

Panacea Biotec Synopsis

NSE-Medical-Generic Drugs

Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 235.50 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2022. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.
Market Cap 695
Sales 224
Shares in Float 1.59
No of funds 7
Yield
Book Value 1.77
U/D Vol ratio 0.8
LTDebt / Equity 20
Alpha -0.15
Beta 0.53

Panacea Biotec

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 73.59%73.59%73.59%
Mutual Funds
Foreign Portfolio Investors 0.18%0.14%
Individual Investors 15.97%15.79%15.6%
Others 10.26%10.48%10.81%

Panacea Biotec Management

Name Designation
Mr. Soshil Kumar Jain Chairman
Dr. Rajesh Jain Managing Director
Mr. Sandeep Jain Joint Managing Director
Mr. Ankesh Jain Whole Time Director
Mr. R L Narasimhan Non Executive Director
Mr. N N Khamitkar Non Executive Director
Mr. K M Lal Non Executive Director
Mrs. Manjula Upadhyay Non Executive Director
Mr. Bhupinder Singh Non Executive Director
Mr. Mukul Gupta Non Executive Director
Mr. Narotam Kumar Juneja Non Executive Director

Panacea Biotec Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Panacea Biotec MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Panacea Biotec FAQs

What is Share Price of Panacea Biotec ?

Panacea Biotec share price is ₹113 As on 23 March, 2023 | 01:00

What is the Market Cap of Panacea Biotec ?

The Market Cap of Panacea Biotec is ₹695.2 Cr As on 23 March, 2023 | 01:00

What is the P/E ratio of Panacea Biotec ?

The P/E ratio of Panacea Biotec is 0.6 As on 23 March, 2023 | 01:00

What is the PB ratio of Panacea Biotec ?

The PB ratio of Panacea Biotec is 0.8 As on 23 March, 2023 | 01:00

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number